|
|||||||
We are specialized in developing next-generation breakthrough products that make a true difference in patients’ lives. Our investigations are committed to providing the next wave of safer, proficient, and cost-effective molecular-based treatment strategies, dedicated to the individualization of therapy. FyMed now supports clients with clinical trial management and research services to accelerate therapeutic development.
Get the specifics
 Collaborate with FyMed
|
|
Advanced. Revolutionary.
With unparalleled pioneering research, FyMed has developed revolutionary pharmacogenomic and pharmacoproteomic targets that change the very dynamics of clinical practice. Safe. Individualized. Proficient. FyMed’s CRO services enhance clinical trial execution, ensuring robust therapeutic outcomes.
 Rx bar none. A molecule that breathes life and restores chronically damaged tissue.
 Enhanced clinical trials. Cutting-edge tools using bioinformatics and FileMaker Pro.
 Tested. To the limits. Novel. Both treat and prevent persistent invasive infections.
 Precisely specific. Homing competency. Targeted. Strategically heals.
Therapeutics Milestones
2011Launched CRO services for therapeutic clinical trials: Supporting biotech innovation
2020Supported a Phase III trial for a therapeutic candidate: Advancing precision medicine
Partner with FyMed for clinical research solutionsContact FyMed to explore our CRO services for your therapeutic trials. Learn more. |
Preemptive. Targeted. Precise.
Our molecular-based precision medicine approach allows for targeting modalities with innovative techniques that are focused and elaborate.
|
|
FyMed, Inc.
Leading Innovations in Precision Medicine ™
Pharmaceuticals:
103 Carnegie Center Dr, #300,
Princeton,
NJ
08540
Corporate:
3422 Old Capitol Rd, #1610,
Wilmington,
DE
19808
USA Tel:
+1 302-722-5010 |
Fax: +1 302-722-5011
UK Tel:
+44 1844 220 090 |
ask@fymedinc.com
Copyright © FyMed, Inc. |
All Rights Reserved
